These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Diagnosis and therapy of nonalcoholic steatohepatitis. Torres DM; Harrison SA Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547 [TBL] [Abstract][Full Text] [Related]
51. [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management]. Spahr L; Hadengue A Rev Med Suisse; 2005 Sep; 1(31):2032-4. PubMed ID: 16212005 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Hyogo H; Tazuma S; Arihiro K; Iwamoto K; Nabeshima Y; Inoue M; Ishitobi T; Nonaka M; Chayama K Metabolism; 2008 Dec; 57(12):1711-8. PubMed ID: 19013295 [TBL] [Abstract][Full Text] [Related]
53. Alcoholic and nonalcoholic forms of fatty liver disease. Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346 [TBL] [Abstract][Full Text] [Related]
54. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M Liver Int; 2007 May; 27(4):423-33. PubMed ID: 17403181 [TBL] [Abstract][Full Text] [Related]
55. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597 [TBL] [Abstract][Full Text] [Related]